[Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
Escudero Barrilero
A
A
Servicio de Urología, Hospital Ramón y Cajal, Madrid, España.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D003131:Combined Modality Therapy; D015653:Cystectomy; D005069:Evaluation Studies as Topic; D006801:Humans; D006979:Hyperthermia, Induced; D007372:Interferons / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011184:Postoperative Period; D011300:Preoperative Care; D011379:Prognosis; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy
D000970:Antineoplastic Agents; D007372:Interferons
Valor de la radioterapia en el tratamiento del cáncer vesical infiltrante.